查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1619482

2024 年心臟标记测试全球市场报告

Cardiac Marker Testing Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

心臟标记检测市场规模预计在未来几年将快速成长。 2028年，将以10.2%的复合年增长率成长至93.5亿美元。预测期内的增长可归因于心血管疾病患病率的上升、战略联盟和伙伴关係数量的增加、研发倡议的扩大、有利的报销政策以及对照护现场(POC) 检测的需求不断增长。预测期内预计的主要趋势包括诊断技术的进步、自动分析仪的使用、先进心臟标记检测方法的开发、数位健康技术的整合以及整合技术的出现。

心血管疾病的日益普及预计将在未来几年推动心臟标记检测市场的成长。心血管疾病 (CVD) 包括冠状动脉疾病、心臟衰竭和中风等影响心臟和血管的疾病。不健康饮食、缺乏运动、吸烟、过量饮酒和空气污染等因素导致心血管疾病病例增加。心臟标记检测在诊断心血管疾病、评估严重程度以及透过检测心肌损伤期间释放的特定生物标记监测治疗进展方面发挥着重要作用。例如，美国心臟协会2024年1月报告称，心血管疾病的年龄调整死亡率增加了4.0%，从2023年的每10万人224.4人死亡增加到每10万人233.3人。此外，2021 年美国有 20,114 人死于心臟麻痹。因此，心血管疾病发生率的增加推动了对心臟标记检测的需求。

心臟标记检测市场的主要企业专注于开发先进的产品，例如心臟检测，提供有关心臟健康和功能的准确且有价值的资讯。这些检测是诊断测试，旨在测量血液或其他样本中的生物标记和其他指标，以帮助评估心臟功能、诊断心血管疾病并评估心臟相关疾病的风险。例如，2023年10月，中国医疗设备公司迈瑞宣布推出肌钙蛋白I（hs-cTnI）和NT-proBNP心臟生物标记。 hs-cTnI 检测在第99 个百分位数的检测极限(LoD) 和参考上限(URL) 之间实现了93% 的检出率，第99 个百分位数的不精确变异係数(CV) ≤ 5% URL以其高灵敏度、高精度、高可靠性而受到关注，超越了最低要求。因此，它对于检测心肌损伤非常有效。迈瑞的 NT-proBNP检测法是心臟衰竭的关键心臟标记物，提供 CV<=5% 的高精度，最大限度地减少 55 种常见心臟治疗的干扰，并为心臟衰竭提供准确的诊断。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球心臟标记测试市场：驱动因素和限制因素
    • 市场驱动因素
    • 市场限制因素
  • 全球心臟标记检测市场表现：规模与成长，2018-2023
  • 全球心臟标记测试市场预测：规模和成长，2023-2028 年、2033 年

第六章 市场细分

  • 全球心臟标记测试市场：按产品、性能和预测，2018-2023、2023-2028、2033
  • 试剂和套件
  • 装置
  • 全球心臟标记测试市场：按生物标记类型分類的表现和预测，2018-2023、2023-2028、2033
  • 肌钙蛋白 I 和 T
  • 肌酸激酶-MB (CK-MB)
  • 利尿钠肽
  • 肌红蛋白
  • 高敏C反应蛋白
  • 其他心臟生物标记
  • 全球心臟标记测试市场：按应用、性能和预测划分，2018-2023、2023-2028、2033
  • 实验室测试设施
  • 就地检验设施
  • 学术机构

第 7 章 区域/国家分析

  • 全球心臟标记测试市场：按地区、表现和预测，2018-2023、2023-2028、2033
  • 全球心臟标记检测市场：按国家、表现和预测，2018-2023年、2023-2028年、2033年

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 心臟标记检测市场：竞争格局
  • 心臟标记测试市场：公司简介
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation
    • Siemens Healthineers AG

第31章 其他大型创新企业

  • Becton Dickinson and Company
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Inc.
  • Tosoh Corporation
  • bioMerieux SA
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Guangzhou Wondfo BIoTech Co. Ltd.
  • Randox laboratories Ltd.
  • Getein BIoTech Inc.
  • Fujirebio Inc.
  • Mayo Clinic Laboratories
  • Kainos Medicine Inc.
  • Alere Inc.
  • Nano-Ditech Corporation

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来展望与潜力分析

第36章附录

简介目录
Product Code: r20513

Cardiac marker testing involves a series of diagnostic tests designed to measure specific substances in the blood that signal damage or stress to the heart. These markers, often proteins or enzymes, are released into the bloodstream when the heart muscle is injured. Cardiac marker tests are vital for diagnosing and assessing conditions such as myocardial infarction (heart attack), heart failure, and other heart-related diseases.

The primary products used in cardiac marker testing include reagents, kits, and instruments. Reagents and kits are crucial components in these tests, containing the necessary chemicals and materials for conducting diagnostics. They provide various biomarkers, such as troponin I and T, creatine kinase-MB (CK-MB), natriuretic peptide, myoglobin, high-sensitivity C-reactive protein, and others, and are utilized in laboratory testing facilities, point-of-care testing facilities, and academic institutions.

The cardiac marker testing market research report is one of a series of new reports from The Business Research Company that provides cardiac marker testing market statistics, including cardiac marker testing industry global market size, regional shares, competitors with a cardiac marker testing market share, detailed cardiac marker testing market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac marker testing industry. This cardiac marker testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac marker testing market size has grown rapidly in recent years. It will grow from $5.92 billion in 2023 to $6.52 billion in 2024 at a compound annual growth rate (CAGR) of 10%. The growth during the historical period can be attributed to the increase in the geriatric population, the rise in educational campaigns, growing awareness, the expansion of healthcare infrastructure, and the increasing patient population.

The cardiac marker testing market size is expected to see rapid growth in the next few years. It will grow to $9.35 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. The growth during the forecast period can be attributed to the rising incidence of cardiovascular diseases, increasing strategic collaborations and partnerships, expanding research and development initiatives, favorable reimbursement policies, and growing demand for point-of-care (POC) testing. Key trends anticipated in the forecast period include advancements in diagnostic technologies, the use of automated analyzers, the development of advanced cardiac marker testing assays, the integration of digital health technologies, and the emergence of integrative technologies.

The increasing prevalence of cardiovascular diseases is anticipated to drive the growth of the cardiac marker testing market in the coming years. Cardiovascular diseases (CVDs), encompassing conditions such as coronary artery disease, heart failure, and stroke, affect the heart and blood vessels. Factors such as unhealthy diets, lack of physical activity, tobacco use, excessive alcohol consumption, and air pollution contribute to the rise in CVD cases. Cardiac marker testing plays a crucial role in diagnosing cardiovascular diseases, assessing their severity, and monitoring treatment progress by detecting specific biomarkers released during myocardial injury. For instance, the American Heart Association reported in January 2024 that the age-adjusted death rate from cardiovascular disease increased by 4.0%, from 224.4 per 100,000 in 2023 to 233.3 per 100,000. Additionally, sudden cardiac arrest accounted for 20,114 deaths in the U.S. in 2021. As a result, the growing incidence of cardiovascular diseases is fueling the demand for cardiac marker testing.

Leading companies in the cardiac marker testing market are focusing on the development of advanced products, such as cardiac assays, to provide accurate and valuable information regarding heart health and function. These assays are diagnostic tests designed to measure biomarkers or other indicators in blood or other samples, helping to assess heart function, diagnose cardiovascular diseases, and evaluate the risk of heart-related conditions. For example, in October 2023, Mindray, a medical device company based in China, introduced the troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTnI assay is notable for its high sensitivity, precision, and reliability, surpassing the minimum requirements by achieving a 93% detection rate between the limit of detection (LoD) and the 99th percentile upper reference limit (URL), and maintaining an imprecision coefficient of variation (CV) below 5% at the 99th URL. This makes it highly effective in detecting myocardial injury. Mindray's NT-proBNP assay is a key cardiac marker for heart failure, offering high precision with a CV of <=5% and minimizing interference from 55 common heart disease medications, ensuring accurate detection and management of heart failure.

In August 2024, VION Biosciences, a US-based life sciences platform, acquired Ansh Labs for an undisclosed amount. This acquisition is intended to bolster VION Biosciences' presence in the diagnostic sector, integrate advanced technologies, and expand its product offerings in immunoassay development. Ansh Labs is a US-based biotechnology company.

Major companies operating in the cardiac marker testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Tosoh Corporation, bioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., Guangzhou Wondfo Biotech Co. Ltd., Randox laboratories Ltd., Getein Biotech Inc., Fujirebio Inc., Mayo Clinic Laboratories, Kainos Medicine Inc., Alere Inc., Nano-Ditech Corporation, 1Drop Diagnostics

North America was the largest region in the cardiac marker testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac marker testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac marker testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiac marker testing market consists of revenues earned by entities by providing services such as homocysteine testing, cardiac stress testing, genetic testing for cardiovascular risk, remote monitoring and telemedicine services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac marker testing market also includes sales of lipoprotein(a) test kits, cardiac biomarker panels, point-of-care testing devices and related products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Marker Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac marker testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac marker testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiac marker testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Reagents And Kits; Instruments
  • 2) By Biomarker Type: Troponin I And T; Creatine Kinase-MB (CK-MB); Natriuretic Peptide; Myoglobin; High-Sensitivity C-Reactive Protein; Other Cardiac Biomarkers
  • 3) By Application: Laboratory Testing Facilities; Point-Of-Care Testing Facilities; Academic Institutions
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiac Marker Testing Market Characteristics

3. Cardiac Marker Testing Market Trends And Strategies

4. Cardiac Marker Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Cardiac Marker Testing Market Size and Growth

  • 5.1. Global Cardiac Marker Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Cardiac Marker Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Cardiac Marker Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cardiac Marker Testing Market Segmentation

  • 6.1. Global Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Reagents And Kits
  • Instruments
  • 6.2. Global Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Troponin I And T
  • Creatine Kinase-MB (CK-MB)
  • Natriuretic Peptide
  • Myoglobin
  • High-Sensitivity C-Reactive Protein
  • Other Cardiac Biomarkers
  • 6.3. Global Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Laboratory Testing Facilities
  • Point-Of-Care Testing Facilities
  • Academic Institutions

7. Cardiac Marker Testing Market Regional And Country Analysis

  • 7.1. Global Cardiac Marker Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Cardiac Marker Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cardiac Marker Testing Market

  • 8.1. Asia-Pacific Cardiac Marker Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cardiac Marker Testing Market

  • 9.1. China Cardiac Marker Testing Market Overview
  • 9.2. China Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cardiac Marker Testing Market

  • 10.1. India Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cardiac Marker Testing Market

  • 11.1. Japan Cardiac Marker Testing Market Overview
  • 11.2. Japan Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cardiac Marker Testing Market

  • 12.1. Australia Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cardiac Marker Testing Market

  • 13.1. Indonesia Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cardiac Marker Testing Market

  • 14.1. South Korea Cardiac Marker Testing Market Overview
  • 14.2. South Korea Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cardiac Marker Testing Market

  • 15.1. Western Europe Cardiac Marker Testing Market Overview
  • 15.2. Western Europe Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cardiac Marker Testing Market

  • 16.1. UK Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cardiac Marker Testing Market

  • 17.1. Germany Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cardiac Marker Testing Market

  • 18.1. France Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cardiac Marker Testing Market

  • 19.1. Italy Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cardiac Marker Testing Market

  • 20.1. Spain Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cardiac Marker Testing Market

  • 21.1. Eastern Europe Cardiac Marker Testing Market Overview
  • 21.2. Eastern Europe Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cardiac Marker Testing Market

  • 22.1. Russia Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cardiac Marker Testing Market

  • 23.1. North America Cardiac Marker Testing Market Overview
  • 23.2. North America Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cardiac Marker Testing Market

  • 24.1. USA Cardiac Marker Testing Market Overview
  • 24.2. USA Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cardiac Marker Testing Market

  • 25.1. Canada Cardiac Marker Testing Market Overview
  • 25.2. Canada Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cardiac Marker Testing Market

  • 26.1. South America Cardiac Marker Testing Market Overview
  • 26.2. South America Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cardiac Marker Testing Market

  • 27.1. Brazil Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cardiac Marker Testing Market

  • 28.1. Middle East Cardiac Marker Testing Market Overview
  • 28.2. Middle East Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cardiac Marker Testing Market

  • 29.1. Africa Cardiac Marker Testing Market Overview
  • 29.2. Africa Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cardiac Marker Testing Market Competitive Landscape And Company Profiles

  • 30.1. Cardiac Marker Testing Market Competitive Landscape
  • 30.2. Cardiac Marker Testing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Abbott Laboratories
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Danaher Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Siemens Healthineers AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Cardiac Marker Testing Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company
  • 31.2. Laboratory Corporation of America Holdings
  • 31.3. Quest Diagnostics Inc.
  • 31.4. Tosoh Corporation
  • 31.5. bioMerieux SA
  • 31.6. Sysmex Corporation
  • 31.7. Bio-Rad Laboratories Inc.
  • 31.8. Guangzhou Wondfo Biotech Co. Ltd.
  • 31.9. Randox laboratories Ltd.
  • 31.10. Getein Biotech Inc.
  • 31.11. Fujirebio Inc.
  • 31.12. Mayo Clinic Laboratories
  • 31.13. Kainos Medicine Inc.
  • 31.14. Alere Inc.
  • 31.15. Nano-Ditech Corporation

32. Global Cardiac Marker Testing Market Competitive Benchmarking

33. Global Cardiac Marker Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cardiac Marker Testing Market

35. Cardiac Marker Testing Market Future Outlook and Potential Analysis

  • 35.1 Cardiac Marker Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Cardiac Marker Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Cardiac Marker Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer